Department of Cardiovascular Surgery, Chiba University Hospital, 1-8-1 Inohana, Chuo Ward, Chiba, Chiba, 260-0856, Japan.
Department of Healthcare Quality Assessment, The University of Tokyo Graduate School of Medicine, Tokyo, Bunkyo-ku, Hongo 7-3-1, Tokyo, 113-0033, Japan.
Gen Thorac Cardiovasc Surg. 2023 Oct;71(10):543-551. doi: 10.1007/s11748-023-01925-8. Epub 2023 Mar 28.
Operative indication of the additional mitral repair for moderate ischemic mitral regurgitation (MR) in the setting of coronary artery bypass grafting (CABG) is still unclear.
This study was designed as the nation-wide multi-center retrospective analysis with additional survival data. CABGs without past heart surgery registered in 2014 and 2015 were included. Concomitant surgery other than tricuspid or arrhythmia surgery, mitral replacement, and off-pump cases, was excluded. Grade 1 or 4 MR, and ejection fraction < 20 or > 50 were excluded. Additional questionnaire was sent to each hospital, regarding the pathology of MR and clinical outcomes. Additional data were registered between May 28, 2021 and Dec 31, 2021, and the primary outcomes were all-death and cardiac death. The secondary outcomes were heart failure and cerebrovascular event requiring admission, mitral re-intervention. Patients underwent on-pump CABG (CABG only group 221 cases) and CABG with mitral repair (CABG + Mitral repair group 276 cases) were enrolled.
After Propensity score matching, 362 cases (CABG only 181cases vs CABG + mitral repair 181 cases) were matched. Cox regression model showed no statistical difference in the long-term survival between CABG alone group and combined procedure group (p = 0.52). Cardiac death (p = 1.00), heart failure (p = 0.68), and cerebrovascular event (p - 0.80) requiring admission were not different between groups as well. The incidence of mitral re-intervention was very few (2 cases in CABG only group, 4 cases in CABG + mitral repair group).
In patients with moderate ischemic MR, additional mitral repair to CABG did not improve long-term survival, freedom from heart failure, or cerebrovascular event.
在冠状动脉旁路移植术(CABG)的背景下,对于中度缺血性二尖瓣反流(MR)的手术适应证仍不明确。
本研究是一项全国多中心回顾性分析,并增加了生存数据。纳入 2014 年和 2015 年无既往心脏手术史的 CABG。排除三尖瓣或心律失常手术、二尖瓣置换术和非体外循环的心脏手术。排除 MR 为 1 级或 4 级、射血分数<20 或>50 的患者。向每家医院发送了关于 MR 病理和临床结局的附加问卷。额外数据于 2021 年 5 月 28 日至 2021 年 12 月 31 日注册,主要结局为全因死亡和心脏死亡。次要结局为心力衰竭和需要入院的脑血管事件、二尖瓣再次介入。纳入接受体外循环 CABG(CABG 组 221 例)和 CABG 联合二尖瓣修复术(CABG+二尖瓣修复组 276 例)的患者。
在倾向评分匹配后,共纳入 362 例患者(CABG 组 181 例,CABG+二尖瓣修复组 181 例)。Cox 回归模型显示,CABG 组和联合手术组之间的长期生存率无统计学差异(p=0.52)。心脏死亡(p=1.00)、心力衰竭(p=0.68)和需要入院的脑血管事件(p=0.80)也无差异。二尖瓣再次介入的发生率非常低(CABG 组 2 例,CABG+二尖瓣修复组 4 例)。
对于中度缺血性 MR 的患者,CABG 联合二尖瓣修复并不能改善长期生存率、心力衰竭或脑血管事件的发生。